[EN] PURINE DERIVATIVES, AS NR2B NEGATIVE MODULATORS AND THE USE THEREOF AS MEDICAMENT, IN PARTICULAR FOR TREATING DEPRESSIVE DISORDERS<br/>[FR] DÉRIVÉS DE PURINE, UTILISÉS EN TANT QUE MODULATEURS NÉGATIFS DE NR2B ET LEUR UTILISATION EN TANT QUE MÉDICAMENT, EN PARTICULIER POUR LE TRAITEMENT DE TROUBLES DÉPRESSIFS
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2020245136A1
公开(公告)日:2020-12-10
The present invention relates to novel purines of general formula A processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an association with NR2B negative allosteric modulating properties.
本发明涉及一般式A的新型嘌呤化合物,以及它们的制备方法、含有它们的药物组合物以及它们在治疗中的应用,特别是在与NR2B负性变构调节性质相关的疾病的治疗或预防中的应用。